Tag: share

CHARLOTTE, N.C., June 16, 2026 /PRNewswire/ -- Greenland Mines Ltd ("Greenland Mines" or the "Company") (Nasdaq: GRML) is pleased to announce that it has...

INDIANAPOLIS, June 16, 2026 (GLOBE NEWSWIRE) -- Kite Realty Group (NYSE: KRG), a premier owner and operator of high-quality, open-air grocery-anchored centers and vibrant mixed-use assets, today announced the completion of significant capital allocation activity, including the acquisition of two high-growth, open-air shopping centers, the disposition of six lower growth, non-core assets, and the execution of additional share buybacks.

YY Group completes US$20 million ATM Program, raising approximately US$19.1 million net proceeds for AI, robotics and IFM initiatives.

Complementary upstream and downstream capabilities to enhance integration and enable the combined company to better create value across cycles, products and regions $400+ million...

NEW YORK, June 16, 2026 /PRNewswire/ -- ...

TSX: TVECALGARY, AB, June 16, 2026 /CNW/ - Tamarack Valley Energy Ltd. has successfully closed the previously announced sale of its Charlie Lake assets for...

162 million 5G subscriptions added during the first quarter of 2026, bringing the total to 3.1 billionThe number of commercial differentiated connectivity service offerings...

BEIJING, June 16, 2026 /PRNewswire/ -- Reading the news about the just concluded Second World Conference of Classics in Athens reminds me of my...

AS LHV Group’s May financial results reflected positive performance, with the results of all subsidiaries in line with the financial plan. LHV Group earned a consolidated net profit of EUR 9.1 million in May, with return on equity attributable to shareholders of 14.1%. Among the subsidiaries, AS LHV Pank earned EUR 9.8 million, LHV Bank Ltd EUR 0.3 million, AS LHV Varahaldus EUR 0.2 million and AS LHV Kindlustus EUR 0.4 million in net profit.

REYKJAVIK, Iceland , June 16, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the pricing of its previously announced underwritten public offering (the “Offering”) of 22,666,667 of its ordinary shares at an offering price of $3.75 per share. All ordinary shares to be sold in the Offering will be offered by Alvotech. The Offering is expected to close on or about June 17, 2026, subject to satisfaction of customary closing conditions. The Company has also granted the underwriters a 30-day option to purchase up to an additional 3,400,000 ordinary shares at the public offering price, less underwriting discounts and commissions. Before deducting the underwriting discounts and commissions and offering expenses, the Company expects to receive total gross proceeds of approximately $85 million from the Offering, or approximately $98 million if the underwriters exercise in full their option to purchase additional shares.